Both in vitro and in vivo studies reveal that by triggering pyroptosis and activating the cGAS‐STING pathway, our nanodrugs exhibit potent cytotoxicity and accurate selectivity in eradicating orthotopic breast tumors. Here, CGAS is linked to breast neoplasm.